You are here:
NICE
NICE Guidance
Published Guidance
Ibrutinib for treating Waldenstrom’s macroglobulinaemia
Technology appraisal guidance
Reference number:
TA491
Published:
22 November 2017
This guidance has been updated and replaced by
NICE technology appraisal guidance 795
.